Lightnews — Scholar-powered news

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · 2d

👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM

#AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm

3 5

Reposted by Michael Platten, MD

Science Magazine @science.org · 2d

The October issue of #ScienceImmunology is out!

This month's cover highlights a Review that delves into brain tumor development and examines factors contributing to the immunosuppressive brain tumor microenvironment. Learn about this and more: https://scim.ag/46HgHcl

This month’s cover illustration depicts distinct malignant glioma (upper left) and metastatic (bottom right) TMEs as collages of aperiodic penrose tiles overlaid on a stylized positron emission tomography (PET) scan of the brain.

3 44

Michael Platten, MD @michael-platten.bsky.social · 4d

The immunology of brain tumors | Science Immunology www.science.org/doi/10.1126/...

Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.

The immunology of brain tumors

The cellular and molecular determinants of the antigenicity of brain tumors and the immunosuppressive brain tumor microenvironment are reviewed.

www.science.org

10 21

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · 14d

🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice.
🔗 academic.oup.com/neuro-oncolo...

10 28

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · 15d

💡Only a few seats left for the EANO Tumor Board 2025, taking place on October 15 in Prague. Join us for interactive case-based discussions and expert insights. Registration is free for EANO members. Please register by October 3.
Learn more: www.eano.eu/eanomeetings...

4 5

Reposted by Michael Platten, MD

Oxford Academic @oxfordacademic.bsky.social · Aug 20

Discover Neuro-Oncology Pediatrics, a new #OA journal launched by @eanoassociation.bsky.social & @neuroonc.bsky.social with editorial leadership from EANO, SNO, & ASNO, focused on advancing care for children and young adults with CNS tumors.

See the first articles: oxford.ly/4mNN1iF

Neuro-Oncology Pediatrics - explore the first issue

3 4

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · Aug 20

📣 New journal launch! Neuro-Oncology Pediatrics is live — an open-access journal advancing global research and care for children & young adults with brain tumors.
A joint EANO & @neuroonc.bsky.social initiative.
🔗 Read more: www.eano.eu/about/news/n...
#NeuroOncology @oxfordacademic.bsky.social

4 9

Michael Platten, MD @michael-platten.bsky.social · Jul 29

an incredibly dedicated team of clinical trialists, basic and translational researchers and immune monitoring team @dkfz.bsky.social, @dkfz-iic.bsky.social, I have the privilege to work with with the goal to develop a viable tratment for patients with this devastating disease. 5/5

1 3

Michael Platten, MD @michael-platten.bsky.social · Jul 29

@neurooncologyhd.bsky.social @neurooncotue.bsky.social, Frankfurt, Mannheim, all patients and their relatives, Roche for the in-kind contribution of atezolizumab, the fantastic research collaborators @bihatcharite.bsky.social and HI-TRON, and first and foremost 4/

1 1 4

Michael Platten, MD @michael-platten.bsky.social · Jul 29

in this "reverse translation" trial which was supported by the German Cancer Aid. Huge thanks to @dkfz.bsky.social as the trial sponsor, the fantastic NCT Trial Center, all participating sites from the Neurooncology Working Group @krebsgesellschaft.bsky.social 3/

1 3

Michael Platten, MD @michael-platten.bsky.social · Jul 29

combined with radiotherapy and the immune checkpoint inhibitor atezolizumab. The trial was based on encouraging results in patients with recurrent diffuse midline gliomas

www.nature.com/articles/s41...

We will now follow-up our patiens, analyze the data and continue our analyses 2/

A H3K27M-targeted vaccine in adults with diffuse midline glioma - Nature Medicine

In this compassionate use study, treatment of adult patients with H3K27M-mutant diffuse midline glioma with a long peptide vaccine targeting H3K27M led to vaccine-induced peripheral T cell immune resp...

www.nature.com

1 3

Michael Platten, MD @michael-platten.bsky.social · Jul 29

Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/

1 1 16

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · Jun 18

📣 Have you heard? Registration for #EANO2025, taking place Oct 16-19, 2025 in #Prague (CZ) is open! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology. Early Bird fees available until July 31, 2025. 👉 eano.eu/eano2025/reg... #braincancer #medsky

1 4 8

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · Jun 8

🧠 June 8 is #WorldBrainTumorDay — raising awareness & understanding of brain tumors.
EANO supports progress in #NeuroOncology through research, education & collaboration.
🔗 Learn more: www.eano.eu
#btsm #BrainTumor #Oncology

6 11

Reposted by Michael Platten, MD

Wissenschaftsrat @wissenschaftsrat.de · Jun 4

Wissenschaft braucht verlässliche Infrastrukturen - viele davon liegen noch in den USA. Der WR-Vorsitzende
@wickwolfgang.bsky.social fordert in der @faznet.bsky.social eine europäische Strategie für mehr Unabhängigkeit👉 www.faz.net/aktuell/wiss...
#DigitaleSouveränität #Forschung #Infrastruktur

Der Wissenschaftsrats-Vorsitzende Wolfgang Wick mit dem nebenstehenden Zitat "Wir brauchen eigenständige Wissenschaftsinfrastrukturen in Europa", das aus einem FAZ-Gastbeitrag vom 4.6.25 stammt.

4 6

Reposted by Michael Platten, MD

DKFZ Immunology, Infection and Cancer @dkfz-iic.bsky.social · May 19

Join us this week on Thursday (22nd May) for our next i2 seminar! This week it’s all about T cells in cancer!

1 2

Reposted by Michael Platten, MD

neurooncologyhd.bsky.social @neurooncologyhd.bsky.social · May 15

The organizing committee of the UNITE conference would like to thank all speakers for their excellent presentations and all participants for the valuable discussions. @wickwolfgang.bsky.social @michael-platten.bsky.social

5 10

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · May 15

🧠 Join the next #EANOYoungsters Journal Club on June 5, 16:30–17:30 CEST!
Discussing: "Rapid molecular profiling of CNS tumors" www.nature.com/articles/s41... (Patel et al., Nat Med 2025)
📍Free & open to all EANO members
🔗 www.eano.eu
#NeuroOncology #BrainTumors #JournalClub

5 7

Reposted by Michael Platten, MD

neurooncologyhd.bsky.social @neurooncologyhd.bsky.social · May 15

The second day of the UNITE conference. Today there will also be a contribution from a patient on the book “Alles gut? Alles gut.” by Marlene Assmann. www.jacobystuart.de/buecher-von-...

6 8

Reposted by Michael Platten, MD

Wolfgang Huber @wkhuber.bsky.social · May 14

The SynthImmune project by Heidelberg University& partner institutes advances a "bottom-up" synthetic biology approach to immunotherapies.
Hoping they do well in the German government's Excellence Strategy—anticipating the announcement on 22 May.

Perspective article: www.nature.com/articles/s41...

Bottom-up synthetic immunology - Nature Nanotechnology

This Perspective highlights bottom-up molecular engineering and modular nanobiotechnological approaches for developing effective immunotherapeutics and their potential in personalized medicine.

www.nature.com

7 14

Reposted by Michael Platten, MD

EANO @eanoassociation.bsky.social · May 6

⏱️ Clock is ticking! Final call for abstract submissions for #EANO2025 in #Prague. Don't miss this chance to share your work contribute to the advancement of #NeuroOncology. Submit now via our official event website: www.eano.eu/eano2025/ until May 6, 2025, 23.59 CEST!
@oncoalert.bsky.social

2 7

Michael Platten, MD @michael-platten.bsky.social · May 2

Fantastic initiative - we could offer to provide our predicTCR and makeTCR tools to identify tumor-reactive TCRs and clone them for testing.

www.nature.com/articles/s41...

www.biorxiv.org/content/10.1...

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy - Nature Biotechnology

Tumor-reactive T cell receptors are rapidly identified from lymphocyte scRNA-seq data.

www.nature.com

1 1

Reposted by Michael Platten, MD

neurooncologyhd.bsky.social @neurooncologyhd.bsky.social · May 2

Wir freuen uns, die UNITE-Glioblastom-Konferenz ankündigen zu können, die am 14. und 15. Mai 2025 im DKFZ-Kommunikationszentrum in Heidelberg stattfinden wird. melden Sie sich heute an: www.unite-glioblastoma.de/unite-confer...

UNITE CONFERENCE - UNITE Glioblastoma

Conference

www.unite-glioblastoma.de

1 7

Reposted by Michael Platten, MD

European Research Council (ERC) @erc.europa.eu · Apr 29

🚀 We are proud to launch the new "Ambassadors for the ERC" initiative, together with @ercgrantees.bsky.social !

We aim to empower researchers across Europe to advocate for frontier research. Find out more 👉 bit.ly/44bQzp7

🌟 Excited to see what can be achieved!

#Amb4ERC

1 18 52

Reposted by Michael Platten, MD

Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · Apr 30

@michael-platten.bsky.social has been selected and nominated as Ambassador for the ERC network. The @erc.europa.eu & the @ercgrantees.bsky.social launched the new Ambassadors on 28 April. This joint initiative aims to promote investment in frontier research and highlight the importance of #research.

8 32